Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate in asymptomatic recurrent prostate cancer
NCT00005073Phase 3Terminated
- Sponsor
- Novartis
- Start
- Sep 1999
- Primary completion
- Mar 2003
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in prostate cancer (PCa), sponsored by Novartis. Started Sep 1999; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00005073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005073.